FDA approves Horizon's drug for thyroid eye disease
January 21, 2020 at 14:59 PM EST
The U.S. Food and Drug Administration has approved Horizon Therapeutics Plc's treatment for thyroid eye disease, the agency said on Tuesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|